NCT04117945 2024-09-27Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal CancerAcademic and Community Cancer Research UnitedPhase 2 Active not recruiting22 enrolled 17 charts